Neurosense Therapeutics Ltd Share Price Today: Live Updates & Key Insights
Neurosense Therapeutics Ltd share price today is $0.76, up -4.53%. The stock opened at $0.7798 against the previous close of $0.7887, with an intraday high of $0.8148 and low of $0.771.
Neurosense Therapeutics Ltd Share Price Chart
Neurosense Therapeutics Ltd
Neurosense Therapeutics Ltd Share Price Performance
Neurosense Therapeutics Ltd Institutional Holdings
Neurosense Therapeutics Ltd Market Status
Neurosense Therapeutics Ltd Fundamentals
Market Cap 27.11 M
PB Ratio 12.8162
PE Ratio 0.0
Enterprise Value 21.84 M
Total Assets 4.58 M
Volume 165991
Neurosense Therapeutics Ltd Company Financials
About Neurosense Therapeutics Ltd & investment objective
Company Information NeuroSense Therapeutics Ltd., a clinical-stage biotechnology company, focuses on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases in the United States and internationally. The company's lead product is PrimeC, an extended-release oral formulation of a fixed-dose combination of ciprofloxacin and celecoxib, currently under Phase 2b/3 clinical trials for the treatment of amyotrophic lateral sclerosis, and completed Phase 2 clinical trials for the treatment of Alzheimer's, as well as under preclinical studies for the treatment of Parkinson's disease. Its preclinical pipeline includes StabiliC for the treatment of Parkinson's disease; and CogniC for the treatment of Alzheimer's disease. The company was incorporated in 2017 and is headquartered in Herzliya, Israel.
Organisation Biotechnology
Employees 17
Industry Biotechnology
CEO Mr. Alon Ben-Noon
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:
Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*
Take your next step
Neurosense Therapeutics Ltd FAQs
What is the share price of Neurosense Therapeutics Ltd today?
The current share price of Neurosense Therapeutics Ltd is $0.76.
Can I buy Neurosense Therapeutics Ltd shares in India?
Yes, Indian investors can buy Neurosense Therapeutics Ltd shares by opening an international trading and demat account with Motilal Oswal.
How to buy Neurosense Therapeutics Ltd shares in India?
You can easily invest in Neurosense Therapeutics Ltd shares from India by:
- Direct Investment:
Opening an international trading account with Motilal Oswal which includes KYC verification in the US. Your account gets activated in a few minutes to a few hours, after which you can start adding funds in USD balance to buy Neurosense Therapeutics Ltd shares. - Indirect Investment:
Under this form of investment, you can choose either a Mutual Fund (MF) or an Exchange-Traded Fund (ETF) that invests in global shares and start investing in shares of Neurosense Therapeutics Ltd.
Can I buy fractional shares of Neurosense Therapeutics Ltd?
Yes, many platforms allow you to buy fractional shares starting from as low as $1.
What is the market capitalization value of Neurosense Therapeutics Ltd?
Neurosense Therapeutics Ltd has a market cap of $27.11 M.
In which sector does Neurosense Therapeutics Ltd belong?
Neurosense Therapeutics Ltd operates in the Biotechnology sector.
What documents are required to invest in Neurosense Therapeutics Ltd stocks?
To invest, you typically need:
What is the PE and PB ratio of Neurosense Therapeutics Ltd?
The PE ratio of Neurosense Therapeutics Ltd is N/A and the PB ratio is 12.82.